azasetron,
azasetron, (+-)-isomer,
N-(1-azabicyclo(2.2.2)oct-3-yl)-6-chloro-4-methyl-3-oxo-3,4 -dihydro-2H-1,4-benzoxazine-8-carboxamide hydrochloride,
Y 25130,
Y-25130,
azasetron hydrochloride,
123040-16-4,
Azasetron HCl,
Serotone,
123040-69-7,
Azasetron (hydrochloride),
Y-25130 hydrochloride,
141922-90-9,
C17H20ClN3O3.HCl,
Azasetron hydrochloride [JAN],
Y 25130,
123040-93-7,
6-chloro-4-methyl-3-oxo-N-(quinuclidin-3-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxamide hydrochloride,
Azasetron hydrochloride (JAN),
2H-1,4-Benzoxazine-8-carboxamide, 3,4-dihydro-N-1-azabicyclo(2.2.2)oct-3-yl-6-chloro-4-methyl-3-oxo-, monohydrochloride,
2H-1,4-Benzoxazine-8-carboxamide, N-1-azabicyclo(2.2.2)oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-, monohydrochloride,
N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide hydrochloride,
SMR000466285,
azasetron-hcl,
6-chloro-4-methyl-3-oxo-N-quinuclidin-3-yl-1,4-benzoxazine-8-carboxamide hydrochloride,
Serotone (TN),
N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide;hydrochloride,
Azasetron hydrochlorid,
Nazasetron hydrochloride,
AC1L3GCQ,
NPFAPI-08,
(+)-Azasetron hydrochloride,
(-)-Azasetron hydrochloride,
Azastron Hydrochloride ,(S),
MLS000758245,
MLS001424223,
MLS006011207,
SCHEMBL442156,
Jsp001546,
CHEBI:31246,
CTK8E8243,
AOB5582,
DBMKBKPJYAHLQP-UHFFFAOYSA-N,
Y-25130 HCl,
BCP12756,
HY-B0068,
KS-00000IQ2,
ABP001086,
BN0548,
MFCD00209913,
RTA-01012,
s2106,
AKOS005766024,
AKOS015914040,
AC-6811,
AN-9647,
API0008826,
CCG-101059,
CS-2459,
NC00309,
123040-95-9,
AK-25334,
AN-31663,
CPD000466285,
H652,
LS-41695,
SAM001247082,
SC-26834,
ACM1216505586,
AB1009466,
AX8017832,
FT-0602906,
FT-0688447,
FT-0689462,
ST24045987,
D01613,
040A164,
A805009,
SR-01000597808,
I06-0644,
I06-1330,
J-004884,
J-004885,
J-519607,
SR-01000597808-1,
I14-43119,
(+)-6-Chloro-4-methyl-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazine-8-carboxylic acid (1-aza-bicyclo[2.2.2]oct-3-yl)-amide hydrochloride,
(-)-6-Chloro-4-methyl-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazine-8-carboxylic acid (1-aza-bicyclo[2.2.2]oct-3-yl)-amide hydrochloride,
123040-94-8,
123040-96-0,
2H-1,4-Benzoxazine-8-carboxamide, N-1-azabicyclo[2.2.2]oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-, hydrochloride (1:1),
6-chloro-3,4-dihydro-4-methyl-3-oxo-N-(3-quinuclidinyl)-2H-1,4-benzoxazine-8-carboxamide hydrochloride,
6-Chloro-4-methyl-3-oxo-3,4-dihydro-2H-benzo[1,4]oxazine-8-carboxylic acid (1-aza-bicyclo[2.2.2]oct-3-yl)-amide hydrochloride,
N-(1-azabicyclo(2.2.2)oct-3-yl)-6-chloro-4-methyl-3-oxo-3,4 -dihydro-2H-1,4-benzoxazine-8-carboxamide hydrochloride,
N-(1-Azabicyclo[2,2,2]oct-3-yl)-6-chloro-4-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-8-carboxamide hydrochloride,
N-(1-Azabicyclo[2.2.2]oct-3-yl)-6-chloro-4-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-8-carboxamide hydrochloride,
N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloranyl-4-methyl-3-oxidanylidene-1,4-benzoxazine-8-carboxamide hydrochloride,
N-(1-Azabicyclo[2.2.2]octan-8-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide hydrochloride,
Azasetron,
Nazasetron,
Azasetron [INN],
UNII-2BSS7XL60S,
Azasetron [superceded RN],
Azasetron-d3 Hydrochloride,
D09ZSA,
UNII-77HC7URR9Z,
2BSS7XL60S,
C17H20ClN3O3.ClH,
C17-H20-Cl-N3-O3,
CID115000,
C17-H20-Cl-N3-O3.Cl-H,
ACN-048112,
WR85915,
Y-25130,
(+-)-6-chloro-3,4-dihydro-4-methyl-3-oxo-N-(3-quinuclidinyl)-2H-1,4-benzoxazine-8-carboxamide,
123039-99-6,
477243-03-1,
N-1-Azabicyclo[2.2.2]oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzoxazine-8-carboxamide,